文献速递类风湿关节炎

类风湿关节炎专用心血管风险评分并不优于通用评分:七国患者验证分析

Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries.
PubMed 文献 · Rheumatology (Oxford) · 2017-01-01

该研究纳入七个国家1796例无既往心血管疾病的类风湿关节炎患者,平均随访6.9年,比较QRISK2、EULAR 1.5乘数、ERS-RA与通用风险计算器对心血管事件的预测效能。结果显示上述RA专用工具并未比通用计算器更准确预测心血管风险。

要点

  • QRISK2、EULAR乘数和ERS-RA在RA患者中未比通用计算器更准确预测CVD。
  • ERS-RA与FRS-ATP、Reynolds风险均值相近,QRISK2明显高估风险。
  • 各工具区分度无显著差异,净重分类改善有限。

核心结论

  • QRISK2、EULAR乘数和ERS-RA算法在RA患者中并未比通用人群心血管风险计算器更准确预测CVD风险。

研究设计与样本

  • 研究合并英国、挪威、荷兰、美国、南非、加拿大和墨西哥七个RA队列,纳入1796例无既往CVD的RA患者,平均年龄54.0岁(s.d. 14.0),女性占74%,平均随访6.9年(12430人年)。
  • 采用标准化定义收集基线CVD危险因素、RA特征和CVD结局(包括心肌梗死、缺血性卒中和心血管死亡),用c统计量和净重分类指数比较QRISK2、EULAR乘数、ERS-RA与ACC/AHA、FRS-ATP、Reynolds风险评分的预测效能。

主要发现

  • 随访期间100例患者发生CVD事件。
  • ERS-RA估计的CVD风险均值(s.d.)为8.8%(9.8%),与FRS-ATP的9.1%(8.3%)和Reynolds的9.2%(12.2%)相近,但低于ACC/AHA的9.8%(12.1%)。
  • QRISK2明显高估风险,均值(s.d.)为15.5%(13.9%)。
  • 区分度方面,ERS-RA(c统计量=0.69)、QRISK2及EULAR乘数应用于ACC/AHA时,与ACC/AHA(c统计量=0.72)相比均未改善,FRS-ATP的c统计量为0.75。
  • ERS-RA的净重分类指数较低:相对于ACC/AHA为-0.8%,相对于FRS-ATP为2.3%。

临床怎么用

  • 在RA患者中,RA专用心血管风险评分(QRISK2、EULAR乘数、ERS-RA)并不优于通用风险计算器,临床选择风险工具时需注意此验证结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Cardiovascular disease (CVD) risk calculators developed for the general population do not accurately predict CVD events in patients with RA. We sought to externally validate risk calculators recommended for use in patients with RA including the EULAR 1.5 multiplier, the Expanded Cardiovascular Risk Prediction Score for RA (ERS-RA) and QRISK2. METHODS: Seven RA cohorts from UK, Norway, Netherlands, USA, South Africa, Canada and Mexico were combined. Data on baseline CVD risk factors, RA characteristics and CVD outcomes (including myocardial infarction, ischaemic stroke and cardiovascular death) were collected using standardized definitions. Performance of QRISK2, EULAR multiplier and ERS-RA was compared with other risk calculators [American College of Cardiology/American Heart Association (ACC/AHA), Framingham Adult Treatment Panel III Framingham risk score-Adult Treatment Panel (FRS-ATP) and Reynolds Risk Score] using c-statistics and net reclassification index. RESULTS: Among 1796 RA patients without prior CVD [mean ( s . d .) age: 54.0 (14.0) years, 74% female], 100 developed CVD events during a mean follow-up of 6.9 years (12430 person-years). Estimated CVD risk by ERS-RA [mean ( s . d .) 8.8% (9.8%)] was comparable to FRS-ATP [mean ( s . d .) 9.1% (8.3%)] and Reynolds [mean ( s . d .) 9.2% (12.2%)], but lower than ACC/AHA [mean ( s . d .) 9.8% (12.1%)]. QRISK2 substantially overestimated risk [mean ( s . d .) 15.5% (13.9%)]. Discrimination was not improved for ERS-RA (c-statistic = 0.69), QRISK2 or EULAR multiplier applied to ACC/AHA compared with ACC/AHA (c-statistic = 0.72 for all) or for FRS-ATP (c-statistic = 0.75). The net reclassification index for ERS-RA was low (-0.8% vs ACC/AHA and 2.3% vs FRS-ATP). CONCLUSION: The QRISK2, EULAR multiplier and ERS-RA algorithms did not predict CVD risk more accurately in patients with RA than CVD risk calculators developed for the general population.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Crowson CS, Gabriel SE, Semb AG, et al. Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries. Rheumatology (Oxford). 2017. PMID: 28339992. doi:10.1093/rheumatology/kex038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。